Sort   by:  
 Page size 
UnknownBiological Knowledge of Thornback Ray (Raja clavata) from the Azores: Improving Scientific Information for the Effectiveness of Species-Specific Management Measures.
Not available
S-EPMC8301307 | biostudies-literature
UnknownStress and the impact of stressful events are lesser among raja yoga meditators – A cross sectional study during COVID-19 pandemic from India
Not available
S-EPMC9270779 | biostudies-literature
UnknownRaja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
Not available
S-EPMC8423298 | biostudies-literature
UnknownTo Be, or Not to Be: That Is the Hamletic Question of Cryptic Evolution in the Eastern Atlantic and Mediterranean Raja miraletus Species Complex.
Not available
S-EPMC10339953 | biostudies-literature
ProteomicsGenetic aberrations in MAP kinase pathway play an important role in erlotinib resistance in head and neck cancer
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase is overexpressed in 90% of Head and neck squamous cell carcinoma (HNSCC) patients. Clinical trials with EGFR-targeted tyrosine kinase inhibitors such as erlotinib have shown a modest activity in HNSCC alternate mechanisms of resist...
ORGANISM(S): Homo sapiens (Human) 
2019-12-18 | PXD007785 | Pride
Head and neck cancer Mass spectrometry Signaling pathways Quantitative phosphoproteomics Egfr-tyrosine kinase inhibitor resistance 
UnknownIdentification and characterization of a novel papillomavirus in thornback skate (<i>Raja clavata</i>).
Not available
S-EPMC12594251 | biostudies-literature
ProteomicsSILAC-based proteomic approach to delineate molecular alterations associated with erlotinib resistance in head and neck squamous cell carcinoma
Although Epidermal growth factor receptor (EGFR) is overexpressed in 90% of Head and neck squamous cell carcinoma (HNSCC) patients. Clinical trials with EGFR-targeted small molecule inhibitors such as erlotinib have shown a modest activity in recurrent or advanced HNSCC. To investigate the acquired ...
ORGANISM(S): Homo sapiens (Human) 
2019-12-18 | PXD007768 | Pride
Head and neck cancer Mass spectrometry Signaling pathways Quantitative proteomics Egfr-tyrosine kinase inhibitor resistance 
ProteomicsSILAC-based quantitative tyrosine phosphoproteomic profiling identifies alternative therapeutic targets to erlotinib in head and neck squamous cell carcinoma
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase is overexpressed in 90% of Head and neck squamous cell carcinoma (HNSCC) patients. Clinical trials with EGFR-targeted tyrosine kinase inhibitors such as erlotinib have shown a modest activity in HNSCC alternate mechanisms of resist...
ORGANISM(S): Homo sapiens (Human) 
2022-10-13 | PXD007769 | Pride
Head and neck cancer Mass spectrometry Signaling pathways Quantitative proteomics Egfr-tyrosine kinase inhibitor resistance 
UnknownRapid development of microsatellite markers with 454 pyrosequencing in a vulnerable fish, the mottled skate, Raja pulchra.
Not available
S-EPMC3397520 | biostudies-literature
UnknownGrowth and mechanical correlations of calcified cartilage in Batoidea: A histomorphological study using the Raja asterias model.
Not available
S-EPMC12327180 | biostudies-literature
Sort   by:  
 Page size